CD14 and rheumatoid arthritis: Consequently, the ratio of CD14+CD16+ to CD14dimCD16+ monocytes in RA patients was six times higher than that in healthy controls (21.83±5.49 fold vs. 3.54±0.94 fold), indicating the selective expansion of CD14+CD16+ monocytes in the peripheral blood of RA patients.